Diabeloop: Launch of a Multi-Country Clinical Study in Adolescents and Young Adults With T1D
23. Februar 2023 02:00 ET
|
Diabeloop SA
BERLIN, Feb. 23, 2023 (GLOBE NEWSWIRE) -- At the International Conference on Advanced Technologies & Treatments for Diabetes, Diabeloop, a leader in Automated Insulin Delivery technology,...
Diabeloop and EOFlow Partner to Offer a Wearable AID With a Smartphone App
11. Januar 2023 23:31 ET
|
Diabeloop SA
PARIS, Jan. 11, 2023 (GLOBE NEWSWIRE) -- EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery systems, and Diabeloop, a leader in diabetes automated...
12-month real-world achievements for Diabeloop's AID
21. September 2022 02:00 ET
|
Diabeloop SA
PARIS, Sept. 21, 2022 (GLOBE NEWSWIRE) -- EASD 2022 - Diabeloop, a leader in therapeutic AI applied to insulin delivery, reports today on 12 months of use of its hybrid closed-loop DBLG1 System on a...
Diabeloop - Key Player in Therapeutic AI Applied to Insulin Delivery - Announces 70 Million Euros New Financing Round to Accelerate Its International Expansion
02. Juni 2022 08:30 ET
|
Diabeloop SA
PARIS, June 02, 2022 (GLOBE NEWSWIRE) -- Diabeloop secures 70 million euros to pursue its solid and sustained growth strategy. The automated insulin delivery pioneer, develops machine-learning...
Diabeloop Presents New Real-Life Results of DBLG1® System
28. April 2022 08:00 ET
|
Diabeloop SA
PARIS, April 28, 2022 (GLOBE NEWSWIRE) -- At ATTD 2022 - Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, presents today new results from a real-life cohort in...
Diabeloop Adapts Its Self-Learning, Personalized Insulin Automatization Software to Be Used With Insulin Pens
12. April 2022 10:00 ET
|
Diabeloop
PARIS, April 12, 2022 (GLOBE NEWSWIRE) -- Diabeloop, a pioneer in the field of therapeutic artificial intelligence, leverages the potential of its diabetes technology to enable the integration of...
Terumo Corporation and Diabeloop SA Enter Into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings
17. November 2021 19:00 ET
|
Diabeloop SA
TOKYO & PARIS, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Terumo Corporation, a global leader in medical technology, and the French company Diabeloop, a pioneer in therapeutic AI, announced today that...